Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
NRG Oncology
Merck Sharp & Dohme LLC
Eli Lilly and Company
Gilead Sciences
Pfizer
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Fundación GECP
Weill Medical College of Cornell University
Phanes Therapeutics
Ohio State University Comprehensive Cancer Center
Fox Chase Cancer Center
Rutgers, The State University of New Jersey